Sustainability is the investment for the future and it is at the core of our business.
Jubilant Life Sciences believes that addressing the challenges of the future rests
on the Triple bottom line of Sustainability.

Business Segments

India Branded Pharmaceuticals

Nurturing Innovation to improve quality of patient’s life

India Branded Pharmaceuticals (IBP) is Jubilant Life Sciences’ Indian venture with a range of pharmaceutical offerings for the Indian Pharmaceuticals Market. The business primarily focuses on products to treat medical conditions in the field of Cardiology and Diabetology. IBP business of the company currently operates with divisions named Spica and Vega, dedicated to delivering high-quality innovative medicines to healthcare professionals and patients across the country.

With a professional team of multi-talented and highly experienced employees, IBP maintains high standards and uncompromising quality in product development. With a drive for excellence, the business has progressively extended its competent work force to over 500 people in a span of two years. There is a culture of excellence in the organization that seeks to continuously enhance our people, process & system capabilities.

IBP has a robust product portfolio including high-quality drugs for the treatment of cardiac and diabetic diseases. The business is continuously involved in research on development of new products and plans to enter into newer segments to offer complete range of products to serve the Indian markets. We lay strong emphasis on compliance related to geography and product specifications as mandated by various regulatory bodies. We also comply with the industry specific needs and product quality standards as per the business requirement.